Article and Video CATEGORIES
Telemedicina y telesalud: cómo COVID 19 ha transformado la atención del cáncer
En este video de discusión, el Dr. Narjust Duma habla con los Dres. Idalid "Ivy" Franco (Programa de Oncología Radioterápica de Harvard), Ana Velázquez Manana (Centro Integral de Cáncer Familiar Helen Diller de UCSF) y Luis Raez (Jefe de Hematología / Oncología y Director Médico - Memorial Cancer Institute).
Para este video, los médicos analizan el COVID-19 y los cambios actuales en la telemedicina, y comparten recomendaciones para los pacientes con cáncer durante la pandemia.
*****
Telemedicine and Telehealth - How COVID 19 has Transformed Cancer Care Covid and Cancer in the Latino Community
In this video discussion, Dr. Narjust Duma speaks with Drs. Idalid "Ivy" Franco (Harvard Radiation Oncology Program), Ana Velazquez Manana (UCSF Helen Diller Family Comprehensive Cancer Center) and Luis Raez (Chief Hematology/Oncology and Medical Director - Memorial Cancer Institute). For this video, the doctors discuss COVID-19 and the current changes in telemedicine, and share recommendations for patients with cancer during the pandemic.
To join the conversation, visit https://cancergrace.org/forum.
Para unirse a la conversación, visite https://cancergrace.org/forum.
Please feel free to offer comments and raise questions in our
discussion forums.
Forum Discussions
Hi Caregiver and welcome to Grace. I'm sorry that you need to be here and hope we can help. Osimertinib has better efficacy than gefitinib (including OS and reaching the brain)...
Hi Bob, Welcome to Grace. I'm sorry about your sil. Unfortunately, cancer becomes resistant to TKIs like tagrisso. Sometimes all of the cancer becomes resistant at once and sometimes just parts...